Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TSR-033 |
Trade Name | |
Synonyms | TSR033|TSR 033 |
Drug Descriptions |
TSR-033 is a humanized monoclonal antibody that targets LAG3 and inhibits binding of class II MHC molecules, potentially resulting in enhanced anti-tumor immune response, particularly in combination with other agents (PMID: 30587557). |
DrugClasses | LAG3 Antibody 18 |
CAS Registry Number | NA |
NCIT ID | C142978 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cobolimab + Dostarlimab-gxly + TSR-033 | Cobolimab Dostarlimab-gxly TSR-033 | 0 | 1 |
Dostarlimab-gxly + TSR-033 | Dostarlimab-gxly TSR-033 | 0 | 0 |
TSR-033 | TSR-033 | 0 | 1 |
TSR-033 + unspecified PD-1 antibody | TSR-033 unspecified PD-1 antibody | 0 | 1 |